menu
    • menu

    Company profile for Dexcel Pharma

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worl...
    Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dexcel PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    1 Dexcel St., Or Akiva, 3060000
    Telephone
    Telephone
    +972 (0)46364000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dexcel.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syremis Pharma Launches With $165M For Mental Health Medicines
    Syremis Pharma Launches With $165M For Mental Health Medicines

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/syremis-therapeutics-launches-with-165m-to-develop-best-in-class-medicines-for-mental-health-condit

    PHARMIWEB
    18 Dec 2025
    Share Share
    OPDP’s 1st enforcement letter of 2025 sent to Dexcel
    OPDP’s 1st enforcement letter of 2025 sent to Dexcel

    03 Mar 2025

    // RAPS

    https://www.raps.org/News-and-Articles/News-Articles/2025/3/OPDP-s-first-enforcement-letter-of-2025-sent-to-De

    RAPS
    03 Mar 2025
    Share Share
    Dexcel`s Generics Tafamidis Receives Tentative Approval in US
    Dexcel`s Generics Tafamidis Receives Tentative Approval in US

    15 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218365

    FDA
    15 Oct 2024
    Share Share
    Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug
    Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug

    12 Aug 2023

    // BLOOMBERG LAW

    https://news.bloomberglaw.com/ip-law/pfizer-scripps-sue-to-block-copy-of-most-expensive-heart-drug

    BLOOMBERG LAW
    12 Aug 2023
    Share Share
    Dexcel's Generic Pantoprazole Sodium Receives Approval in the U.S.
    Dexcel's Generic Pantoprazole Sodium Receives Approval in the U.S.

    16 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216247

    FDA
    16 Jun 2023
    Share Share
    Par Pharma's Generic Isosorbide Dinitrate Receives Approval in the US
    Par Pharma's Generic Isosorbide Dinitrate Receives Approval in the US

    23 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211290

    FDA
    23 Nov 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Dexcel Pharma Technologies Ltd and get a quotation

    Dexcel Pharma Technologies Ltd is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND OPERATING PROCEDURES IN OR AKIVA, ISRAEL bulk offered by Dexcel Pharma Technologies Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search